Cargando…

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

Pharmacogenomic screening can identify patients with gene variants that predispose them to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of the critical metabolic enzyme dihydropyrimidine dehydrogenase (DPD) leads to excessive toxicity on exposure to fluoropy...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Cassandra, Scott, Rodney J, Paul, Christine, Ziolkowski, Andrew, Mossman, David, Ackland, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668257/ https://www.ncbi.nlm.nih.gov/pubmed/34916829 http://dx.doi.org/10.2147/PGPM.S337147

Ejemplares similares

Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity
por: Ockeloen, Charlotte W, et al.
Publicado: (2021)

DPYD genotyping and dihydropyrimidine dehydrogenase (DPD) phenotyping in clinical oncology. A clinically focused minireview
por: Paulsen, Niels Herluf, et al.
Publicado: (2022)

A DPYD variant (Y186C) in individuals of African ancestry associated with reduced DPD enzyme activity
por: Offer, Steven M., et al.
Publicado: (2013)

Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene
por: Maring, J G, et al.
Publicado: (2002)

Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022)

Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study
por: Miarons, Marta, et al.
Publicado: (2023)

DPD status and fluoropyrimidines-based treatment: high activity matters too
por: Chamorey, Emmanuel, et al.
Publicado: (2020)

A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening
por: Tong, Chi C., et al.
Publicado: (2018)

Mutations at codon 974 of the DPYD gene are a rare event.
por: Ridge, S. A., et al.
Publicado: (1997)

Mutations at codon 974 of the DPYD gene are a rare event.
por: Diasio, R. B., et al.
Publicado: (1997)

Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
por: van Staveren, Maurice C., et al.
Publicado: (2011)

Delayed Presentation of DPD Deficiency in Colorectal Cancer
por: Law, Lindsey, et al.
Publicado: (2014)

Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door
por: Donadio, Mauro Daniel Spina, et al.
Publicado: (2022)

Revisiting the Clinical Importance of DPYD*9A (c.85T>C) Variant of Dihydropyrimidine Dehydrogenase (DPYD) Gene in Patients Treated with Fluoropyrimidine-Based Chemotherapy
por: Patel, Girijesh Kumar, et al.
Publicado: (2018)

DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker
por: Scully, Paul R., et al.
Publicado: (2020)

DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
por: Wigle, Theodore J., et al.
Publicado: (2019)

Simulation of tetraetherlipids on solid surfaces – an extension of the DPD-model
por: Engels, Christoph, et al.
Publicado: (2008)

Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping
por: Royer, B., et al.
Publicado: (2023)

Frequency of the DPYD * 2A allele in the Czech population
por: Koudová, Monika, et al.
Publicado: (2014)

New advances in DPYD genotype and risk of severe toxicity under capecitabine
por: Etienne-Grimaldi, Marie-Christine, et al.
Publicado: (2017)

DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients
por: Del Re, Marzia, et al.
Publicado: (2019)

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2019)

Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
por: Zhang, Tingting, et al.
Publicado: (2021)

Scaling and Interactions of Linear and Ring Polymer Brushes via DPD Simulations
por: Jehser, Martin, et al.
Publicado: (2019)

DPD Simulation on the Transformation and Stability of O/W and W/O Microemulsions
por: Li, Menghua, et al.
Publicado: (2022)

Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity
por: Loganayagam, A, et al.
Publicado: (2013)

DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients
por: Amirfallah, Arsalan, et al.
Publicado: (2018)

Genetic Variations of the DPYD Gene and Its Relationship with Ancestry Proportions in Different Ecuadorian Trihybrid Populations
por: Farinango, Camila, et al.
Publicado: (2022)

Implementation and clinical benefit of DPYD genotyping in a Danish cancer population
por: Paulsen, N.H., et al.
Publicado: (2023)

Influence of DPYD*9A, DPYD*6 and GSTP1 ile105val Genetic Polymorphisms on Capecitabine and Oxaliplatin (CAPOX) Associated Toxicities in Colorectal Cancer (CRC) Patients
por: K, Ashok Varma, et al.
Publicado: (2019)

Quantification of (99m)Tc-DPD concentration in the lumbar spine with SPECT/CT
por: Cachovan, Michal, et al.
Publicado: (2013)

Disphosphonates cardiac uptake in familial amyloid neuropathy: Comparison between DPD and HMDP
por: Regaieg, Hamza, et al.
Publicado: (2015)

DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
por: Hutt, David, et al.
Publicado: (2015)

Morphology and Performance of Polymer Solar Cell Characterized by DPD Simulation and Graph Theory
por: Du, Chunmiao, et al.
Publicado: (2015)

The Changes of CTX, DPD, Osteocalcin, and Bone Mineral Density During the Postmenopausal Period
por: Park, Seok Gyo, et al.
Publicado: (2018)

Case report: 5-Fluorouracil treatment in patient with an important partial DPD deficiency
por: Schmitt, Antonin, et al.
Publicado: (2023)

Quantitative (99m)Tc-DPD-SPECT/CT assessment of cardiac amyloidosis
por: Kessler, Lukas, et al.
Publicado: (2022)

Impact of DPYD, DPYS, and UPB1 gene variations on severe drug‐related toxicity in patients with cancer
por: Yokoi, Katsuyuki, et al.
Publicado: (2020)

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2018)

Near Miss or Standard of Care? DPYD Screening for Cancer Patients Receiving Fluorouracil
por: Winquist, Lauren E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q83v9sl7urpin317ug4m6k81k5